LABS Life Science Reit Plc

TIDMLABS

RNS Number : 7151A

Life Science REIT PLC

25 May 2023

Life Science REIT plc

(the "Company")

LEI: 213800RG7JNX7K8F7525

25 May 2023

Annual General Meeting ("AGM") Results

The Company announces that at its Annual General Meeting held earlier today all the resolutions set out in the Notice of Annual General Meeting were passed. All resolutions were voted on by way of a poll. The results of the poll for each resolution were as follows:

 
                                                          For                    Against 
                                                   No. of                 No. of shares     %     Votes Withheld 
                                                    shares          %                                 (No. of 
                  Resolution                                                                          shares) 
 
              1. To receive and approve 
              the annual report and financial 
              statements                          237,307,165    100.00%      10,345       0.00%       19,548 
      2. To receive and approve 
       the Directors' remuneration 
       report                                     236,497,636    99.68%       761,688      0.32%       77,734 
      3. To re-elect Claire Boyle 
       as a Director of the Company               227,063,288    95.69%     10,227,912     4.31%       45,858 
      4. To re-elect Sally Ann Forsyth 
       as a Director of the Company               197,662,892    90.55%     20,630,888     9.45%     19,043,278 
      5. To re-elect Michael Taylor 
       as a Director of the Company               236,321,834    99.59%       969,366      0.41%       45,858 
      6. To re-elect Richard Howell 
       as a Director of the Company               236,350,144    99.59%       969,366      0.41%       17,548 
 
              7. To appoint Deloitte LLP 
              as Auditor to the Company           237,257,249    99.97%       63,261       0.03%       16,548 
 
        8. To authorise the Audit 
        and Risk Committee to determine 
        the remuneration of the Auditor 
        to the Company                            237,267,855    99.99%       24,345       0.01%       44,858 
      9. To approve the Company's 
       dividend payment policy                    237,287,855    100.00%      10,345       0.00%       38,858 
      10. To authorise the Directors 
       to allot equity securities                 228,003,637    96.08%      9,294,563     3.92%       38,858 
 
              11. To authorise the Directors 
              to disapply pre-emption rights*     226,872,038    95.61%     10,420,162     4.39%       44,858 
 
              12. To authorise the Directors 
              to disapply pre-emption rights 
              for the purposes of financing 
              an acquisition or other capital 
              investment*                         225,728,875    95.13%     11,563,325     4.87%       44,858 
 
        13. To approve the purchase 
        of the Company's own shares*              227,477,570    95.87%      9,800,639     4.13%       58,849 
      14. That a general meeting, 
       other than an AGM, may be 
       called on not less than 14 
       clear days' notice*                        236,894,091    99.83%       404,109      0.17%       38,858 
 

*special resolution

 
 NOTES: 
 1.       All resolutions were passed. 
 2.       Percentages have been rounded to two decimal places. 
 3.       Proxy appointments which gave discretion to the Chair 
           of the AGM have been included in the "For" total for 
           the appropriate resolution. 
 4.       Votes "For" and "Against" any resolution are expressed 
           as a percentage of votes validly cast for that resolution. 
 5.       A "Vote withheld" is not a vote in law and is not counted 
           in the calculation of the percentage of shares voted 
           "For" or "Against" any resolution. 
 6.       The number of shares in issue at 6:00 pm. on 23 May 
           2023 was 350,000,000 ordinary shares, carrying one 
           vote each, and at that time, the Company did not hold 
           any shares in treasury. 
 7.       The full text of the resolutions passed at the AGM 
          can be found in the Notice of Annual General Meeting 
          which is available on the Company's website at 
          https://lifesciencereit.co.uk/investors/shareholder-information/ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGAAMATMTBTBJJ

(END) Dow Jones Newswires

May 25, 2023 11:15 ET (15:15 GMT)

Life Science Reit (LSE:LABS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024

Life Science Reit (LSE:LABS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024